Skip to main content
. 2018 Apr 30;12:1019–1031. doi: 10.2147/DDDT.S157104

Table 1.

Inhibitory effect of the dimeric adamantane compounds on p7 protein in GTs 1a, 1b, 2a, 3a, and 4ac

Compound IC50 (nM) ± SEM*
GT1a GT1b GT2a GT3a GT4a
Amantadine 0.7±0.4 (5) 0.6±0.1 (6) >1,000 (5) >100 (4) 3.2±1.2 (5)
Rimantadine 0.7±0.1 (5) 1.7±1.2 (8) 24±4 (5) 1.6±0.6 (5) 3.0±0.8 (4)
2a 0.4±0.1 (5) 1.2±0.2 (3) 2.8±0.3 (4) 2.0±0.4 (4) 1.2±0.2 (4)
2b 0.4±0.1 (4) 0.5±0.4 (3) 0.9±0.1 (3) 0.9±0.3 (4) 0.4±0.1 (5)
2c 1.0±0.2 (7) 0.7±0.2 (4) 0.8±0.1 (6) 0.6±0.1 (9) 0.8±0.1 (7)
2d 0.9±0.1 (3) 1.0±0.3 (4) 0.6±0.1 (4) 0.6±0.1 (4) 0.9±0.2 (4)
2e 0.6±0.1 (4) 1.1±0.2 (4) 0.4±0.1 (3) 0.6±0.1 (5) 0.4±0.1 (6)
4a NA 1.1±0.3 (3) NA NA 0.7±0.2 (4)
4b NA 0.6±0.2 (4) NA NA 2.0±0.1 (3)
4c NA 1.1±0.1 (3) NA NA 0.5±0.1 (4)
4d 0.8±0.2 (3) 2.3±0.2 (4) NA NA 1.1±0.1 (4)
4e NA 1.0±0.3 (7) NA NA 0.8±0.3 (6)
1c 1.2±0.3 (4) 0.5±0.1 (4) >100 (4) 1.0±0.1 (4) 0.8±0.1 (4)
5a 1.3±0.2 (4) 1.0±0.2 (6) NA NA 0.9±0.1 (4)

Note:

*

Numbers in parentheses indicate the number of cells used for measurements.

Abbreviations: GT, genotype; NA, not applicable.